MZP-32118-35909
3 vaccinations
4 coded responses
33 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 926 / CA
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Pfizer-BioNTech
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-07
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-14
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-20
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-15
- 2021-07-15
-
2021-11-12
Dose 3 — Moderna
-
2021-11-13
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · Rash, not including the immediate area around the injection siteFree text: Ancillary o mph node swelling of vaccinated armMedDRA releases: 2024-11 · check-in free text available
-
2021-11-14
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteFree text: Axillary lymph node swelling on vaccinated armMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Axillary lymph node swelling on vaccinated armMedDRA releases: 2024-11 · check-in free text available
- 2021-11-16
- 2021-11-18
- 2021-11-19
- 2021-12-05
- 2021-12-10
- 2021-12-19
- 2021-12-24
-
2022-02-11
Survey response — 3 months, dose 3MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-02-11
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-16
-
2022-02-16
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-05-15
- 2022-11-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-11 | Successful 2022-02-16 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Ancillary o mph node swelling of vaccinated arm
Systemic reaction (other): Axillary lymph node swelling on vaccinated arm
Systemic reaction (other): Axillary lymph node swelling on vaccinated arm
Release 11 — 3 months, dose 3
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release